PDF herunterladen
Thromb Haemost 2024; 124(12): 1143-1151
DOI: 10.1055/s-0044-1786819
Stroke, Systemic or Venous Thromboembolism

Tea Consumption, Milk or Sweeteners Addition, Genetic Variation in Caffeine Metabolism, and Incident Venous Thromboembolism

Hao Xiang
1   Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China
,
Mengyi Liu
1   Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China
,
Chun Zhou
1   Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China
,
Yu Huang
1   Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China
,
Yuanyuan Zhang
1   Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China
,
Panpan He
1   Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China
,
Ziliang Ye
1   Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China
,
Sisi Yang
1   Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China
,
Yanjun Zhang
1   Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China
,
Xiaoqin Gan
1   Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China
,
Xianhui Qin 
1   Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China
› Institutsangaben Funding The study was supported by the National Key Research and Development Program [2022YFC2009600, 2022YFC2009605], the National Natural Science Foundation of China [81973133], Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University [2017J009], and the National Key Research and Development Program [2018ZX09739].
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints


Abstract

Objective The association between tea consumption and venous thromboembolism (VTE) remains unknown. We aimed to evaluate the association between tea consumption with different additives (milk and/or sweeteners) and incident VTE, and the modifying effects of genetic variation in caffeine metabolism on the association.

Methods A total of 190,189 participants with complete dietary information and free of VTE at baseline in the UK Biobank were included. The primary outcome was incident VTE, including incident deep vein thrombosis and pulmonary embolism.

Results During a median follow-up of 12.1 years, 4,485 (2.4%) participants developed incident VTE. Compared with non-tea drinkers, tea drinkers who added neither milk nor sweeteners (hazard ratio [HR]: 0.85; 95% confidence interval [95% CI]: 0.76–0.94), only milk (HR: 0.86; 95% CI: 0.80–0.93), and both milk and sweeteners to their tea (HR: 0.90; 95% CI: 0.81–0.99) had a lower risk of VTE, while those who added only sweeteners to their tea did not (HR: 0.94; 95% CI: 0.75–1.17). Moreover, there was an L-shaped relationship between tea consumption and incident VTE among tea drinkers who added neither milk nor sweeteners, only milk, and both milk and sweeteners to their tea, respectively. However, a nonsignificant association was found among tea drinkers who added only sweeteners to their tea. Genetic variation in caffeine metabolism did not significantly modify the association (p-interaction = 0.659).

Conclusion Drinking unsweetened tea, with or without added milk, was associated with a lower risk of VTE. However, there was no significant association between drinking tea with sweeteners and incident VTE.

Keywords

tea consumption - venous thromboembolism - milk - sweeteners - caffeine metabolism

Data Availability Statement

The UK Biobank data are available on application to the UK Biobank, and the analytic methods and study materials that support the findings of this study will be available from the corresponding authors on request.


Authors' Contribution

H.X. and X.Q. designed and conducted the research; H.X. and C.Z., Z.Y., and X.Q. performed the data management and statistical analyses; H.X., C.Z., and X.Q. wrote the manuscript. All authors reviewed/edited the manuscript for important intellectual content. All authors read and approved the final manuscript.


Supplementary Material



Publikationsverlauf

Eingereicht: 07. Dezember 2023

Angenommen: 11. April 2024

Artikel online veröffentlicht:
10. Mai 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Grosse SD, Nelson RE, Nyarko KA, Richardson LC, Raskob GE. The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs. Thromb Res 2016; 137: 3-10
    CrossrefPubMedSuche in Google Scholar
  • 2 Barco S, Woersching AL, Spyropoulos AC, Piovella F, Mahan CE. European Union-28: an annualised cost-of-illness model for venous thromboembolism. Thromb Haemost 2016; 115 (04) 800-808
    Thieme ConnectPubMedSuche in Google Scholar
  • 3 Di Nisio M, van Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. Lancet 2016; 388 (10063): 3060-3073
    CrossrefPubMedSuche in Google Scholar
  • 4 Pan Y, Feng X, Zhou S. et al. Hydroxyls on the B ring and gallic acyl are essential for catechins to restrain ADP-induced thrombosis. Food Funct 2023; 14 (02) 1037-1047
    CrossrefPubMedSuche in Google Scholar
  • 5 Xing L, Zhang H, Qi R, Tsao R, Mine Y. Recent advances in the understanding of the health benefits and molecular mechanisms associated with green tea polyphenols. J Agric Food Chem 2019; 67 (04) 1029-1043
    CrossrefPubMedSuche in Google Scholar
  • 6 Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol 2023; 20 (04) 248-262
    CrossrefPubMedSuche in Google Scholar
  • 7 Wang Q, Zennadi R. Oxidative stress and thrombosis during aging: the roles of oxidative stress in RBCs in venous thrombosis. Int J Mol Sci 2020; 21 (12) 4259
    CrossrefPubMedSuche in Google Scholar
  • 8 Montoro-García S, Schindewolf M, Stanford S, Larsen OH, Thiele T. The role of platelets in venous thromboembolism. Semin Thromb Hemost 2016; 42 (03) 242-251
    Thieme ConnectPubMedSuche in Google Scholar
  • 9 Reyes CM, Cornelis MC. Caffeine in the diet: country-level consumption and guidelines. Nutrients 2018; 10 (11) 1772
    CrossrefPubMedSuche in Google Scholar
  • 10 Mahdavi S, Palatini P, El-Sohemy A. CYP1A2 genetic variation, coffee intake, and kidney dysfunction. JAMA Netw Open 2023; 6 (01) e2247868
    CrossrefPubMedSuche in Google Scholar
  • 11 Inoue-Choi M, Ramirez Y, Cornelis MC, Berrington de González A, Freedman ND, Loftfield E. Tea consumption and all-cause and cause-specific mortality in the UK Biobank : a prospective cohort study. Ann Intern Med 2022; 175 (09) 1201-1211
    CrossrefPubMedSuche in Google Scholar
  • 12 Wu H, Gu Y, Meng G. et al. Quality of plant-based diet and the risk of dementia and depression among middle-aged and older population. Age Ageing 2023; 52 (05) afad070
    CrossrefPubMedSuche in Google Scholar
  • 13 Liu B, Young H, Crowe FL. et al. Development and evaluation of the Oxford WebQ, a low-cost, web-based method for assessment of previous 24 h dietary intakes in large-scale prospective studies. Public Health Nutr 2011; 14 (11) 1998-2005
    CrossrefPubMedSuche in Google Scholar
  • 14 Bycroft C, Freeman C, Petkova D. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 2018; 562 (7726) 203-209
    CrossrefPubMedSuche in Google Scholar
  • 15 Cornelis MC, Kacprowski T, Menni C. et al; Swiss Kidney Project on Genes in Hypertension (SKIPOGH) team. Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior. Hum Mol Genet 2016; 25 (24) 5472-5482
    PubMedSuche in Google Scholar
  • 16 Malik R, Georgakis MK, Neitzel J. et al. Midlife vascular risk factors and risk of incident dementia: longitudinal cohort and Mendelian randomization analyses in the UK Biobank. Alzheimers Dement 2021; 17 (09) 1422-1431
    CrossrefPubMedSuche in Google Scholar
  • 17 Lichtenstein AH, Appel LJ, Brands M. et al; American Heart Association Nutrition Committee. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114 (01) 82-96
    CrossrefPubMedSuche in Google Scholar
  • 18 Lloyd-Jones DM, Hong Y, Labarthe D. et al; American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010; 121 (04) 586-613
    CrossrefPubMedSuche in Google Scholar
  • 19 Eastwood SV, Mathur R, Atkinson M. et al. Algorithms for the capture and adjudication of prevalent and incident diabetes in UK Biobank. PLoS One 2016; 11 (09) e0162388
    CrossrefPubMedSuche in Google Scholar
  • 20 Nazarzadeh M, Bidel Z, Mohseni H. et al; INVENT Consortium. Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies. Cardiovasc Res 2023; 119 (03) 835-842
    CrossrefPubMedSuche in Google Scholar
  • 21 Jørgensen H, Horváth-Puhó E, Laugesen K, Braekkan S, Hansen JB, Sørensen HT. Socioeconomic status and risk of incident venous thromboembolism. J Thromb Haemost 2021; 19 (12) 3051-3061
    CrossrefPubMedSuche in Google Scholar
  • 22 Becattini C, Agnelli G. Aspirin for prevention and treatment of venous thromboembolism. Blood Rev 2014; 28 (03) 103-108
    CrossrefPubMedSuche in Google Scholar
  • 23 Liu D, Li ZH, Shen D. et al. Association of sugar-sweetened, artificially sweetened, and unsweetened coffee consumption with all-cause and cause-specific mortality : a large prospective cohort study. Ann Intern Med 2022; 175 (07) 909-917
    CrossrefPubMedSuche in Google Scholar
  • 24 Austin PC. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. Stat Med 2016; 35 (30) 5642-5655
    CrossrefPubMedSuche in Google Scholar
  • 25 VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med 2017; 167 (04) 268-274
    CrossrefPubMedSuche in Google Scholar
  • 26 Kang WS, Lim IH, Yuk DY. et al. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb Res 1999; 96 (03) 229-237
    CrossrefPubMedSuche in Google Scholar
  • 27 Deana R, Turetta L, Donella-Deana A. et al. Green tea epigallocatechin-3-gallate inhibits platelet signalling pathways triggered by both proteolytic and non-proteolytic agonists. Thromb Haemost 2003; 89 (05) 866-874
    Thieme ConnectPubMedSuche in Google Scholar
  • 28 Donà M, Dell'Aica I, Calabrese F. et al. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol 2003; 170 (08) 4335-4341
    CrossrefPubMedSuche in Google Scholar
  • 29 Vita JA. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr 2005; 81 (1, Suppl): 292S-297S
    CrossrefPubMedSuche in Google Scholar
  • 30 Tang GY, Meng X, Gan RY. et al. Health functions and related molecular mechanisms of tea components: an update review. Int J Mol Sci 2019; 20 (24) 6196
    CrossrefPubMedSuche in Google Scholar
  • 31 Keller A, Wallace TC. Tea intake and cardiovascular disease: an umbrella review. Ann Med 2021; 53 (01) 929-944
    CrossrefPubMedSuche in Google Scholar
  • 32 Ras RT, Zock PL, Draijer R. Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis. PLoS One 2011; 6 (03) e16974
    CrossrefPubMedSuche in Google Scholar
  • 33 Korir MW, Wachira FN, Wanyoko JK, Ngure RM, Khalid R. The fortification of tea with sweeteners and milk and its effect on in vitro antioxidant potential of tea product and glutathione levels in an animal model. Food Chem 2014; 145: 145-153
    CrossrefPubMedSuche in Google Scholar
  • 34 Yang B, Glenn AJ, Liu Q. et al. Added sugar, sugar-sweetened beverages, and artificially sweetened beverages and risk of cardiovascular disease: findings from the women's health initiative and a network meta-analysis of prospective studies. Nutrients 2022; 14 (20) 4226
    CrossrefPubMedSuche in Google Scholar
  • 35 Choi HJ, Jeon SY, Hong WK. et al. Effect of glucose ingestion in plasma markers of inflammation and oxidative stress: analysis of 16 plasma markers from oral glucose tolerance test samples of normal and diabetic patients. Diabetes Res Clin Pract 2013; 99 (02) e27-e31
    CrossrefPubMedSuche in Google Scholar
  • 36 Lutsey PL, Steffen LM, Virnig BA, Folsom AR. Diet and incident venous thromboembolism: the Iowa Women's Health Study. Am Heart J 2009; 157 (06) 1081-1087
    CrossrefPubMedSuche in Google Scholar
  • 37 Nardini M, Natella F, Scaccini C. Role of dietary polyphenols in platelet aggregation. A review of the supplementation studies. Platelets 2007; 18 (03) 224-243
    CrossrefPubMedSuche in Google Scholar
  • 38 Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet 2021; 398 (10294): 64-77
    CrossrefPubMedSuche in Google Scholar
  • 39 Natella F, Nardini M, Belelli F. et al. Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. Br J Nutr 2008; 100 (06) 1276-1282
    CrossrefPubMedSuche in Google Scholar
  • 40 Lawrenson R, Todd JC, Leydon GM, Williams TJ, Farmer RD. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol 2000; 49 (06) 591-596
    CrossrefPubMedSuche in Google Scholar
  • 41 Cornelis MC, van Dam RM. Habitual coffee and tea consumption and cardiometabolic biomarkers in the UK Biobank: the role of beverage types and genetic variation. J Nutr 2020; 150 (10) 2772-2788
    CrossrefPubMedSuche in Google Scholar